Bausch Plus Lomb (BLCO) stock
NYSE
As of the Nov 13, 2026 close (U.S. Eastern)
- Market cap
- $7.53B
- As of Nov 13, 2026
- P/E
- -67.83x
- Trailing twelve months
- P/B
- 1.17x
- Latest reported equity
- P/S
- 1.39x
- Trailing twelve months
- ROE
- -1.7%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
- Market cap
- $7.53B
- As of Nov 13, 2026
- P/E
- -67.83x
- Trailing twelve months
- P/B
- 1.17x
- Latest reported equity
- P/S
- 1.39x
- Trailing twelve months
- ROE
- -1.7%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 13, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
-67.83x
Net loss — not comparable
P/B
1.17x
P/S
1.39x
Earnings and dividend metrics▾
Earnings
EPS
-$0.31
Earnings per share
BPS
$18.04
Book value per share
ROE
-1.7%
Return on equity
- EPS — what one share earned over the last four quarters. The company is currently loss-making, at $0.31 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $18.04 of net assets.
- ROE — shareholder equity shrank by 1.7% over a year.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 7.3% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $1.28B+7.3%
$1.2B
Jul–Sep '24
$1.28B
Jul–Sep '25
$1.38B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 28, 2026.
- Earnings per share increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
- Revenue increased 7.3% from the same quarter a year earlier.
- Operating income increased 63.2% from the same quarter a year earlier.
- Net income increased from a year earlier. The year-ago value was zero or negative, so no percentage change is shown.
Filed Oct 28, 2026 · 10-Q · SEC EDGAR
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Munsch FrederickSVP, Controller and CAO · Oct 29, 2026Open-market sale112,015 shares · $2.3MAvg. price $20.4845,831 shares held after
- Munsch FrederickSVP, Controller and CAO · Oct 29, 2026Option exercise112,015 shares · $2.0MAvg. price $17.9914
Show 2 price lots
- 87,912 shares × $18$1.6M
- 24,103 shares × $17.96$433K
- ROBERTSON RUSSEL CDirector · Oct 29, 2026Grant or award1,256 shares · $26KAvg. price $20.495,516 shares held after
- Alfonso EduardoDirector · Oct 29, 2026Grant or award1,125 shares · $23KAvg. price $20.432,197 shares held after
- Paulson JohnDirector · Oct 29, 2026Grant or award1,125 shares · $23KAvg. price $20.490,948 shares held after
- Chersi Robert JDirector · Aug 12, 2026Grant or award11,776 shares · $0Avg. price $011,776 shares held after
- Trebbi BarbaraDirector · Aug 12, 2026Grant or award11,776 shares · $0Avg. price $011,776 shares held after
- PAUL LAURENCE EDirector · Aug 12, 2026Grant or award11,776 shares · $0Avg. price $011,776 shares held after
- Munsch FrederickSVP, Controller and CAO · Aug 10, 2026Open-market sale52,900 shares · $888KAvg. price $16.7845,831 shares held after
- VON ESCHENBACH ANDREW C.Director · Aug 7, 2026Open-market sale6,059 shares · $100KAvg. price $16.5863,733 shares held after
- VON ESCHENBACH ANDREW C.Director · Aug 6, 2026Open-market sale12,500 shares · $206KAvg. price $16.569,792 shares held after
- SAUNDERS BRENT LChairman of the Board and CEO · Aug 5, 2026Shares withheld for taxes4,231 shares · $71KAvg. price $16.76974,158 shares held after
- Bonnefoy LucPresident, Surgical · Aug 5, 2026Grant or award16,778 shares · $0Avg. price $0103,801 shares held after
- Eldessouky SamEVP and CFO · Aug 5, 2026Grant or award50,335 shares · $0Avg. price $0393,527 shares held after
- Hashad YehiaEVP of R&D and CMO · Aug 5, 2026Grant or award20,973 shares · $0Avg. price $0187,350 shares held after
- Bailey A Robert DEVP & Chief Legal Officer · Aug 5, 2026Grant or award33,557 shares · $0Avg. price $0264,241 shares held after
- Munsch FrederickSVP, Controller and CAO · Aug 5, 2026Grant or award9,091 shares · $0Avg. price $098,731 shares held after
- Stewart Andrew J.President, GPIC · Aug 5, 2026Grant or award16,778 shares · $0Avg. price $0103,211 shares held after
- SAUNDERS BRENT LChairman of the Board and CEO · Aug 5, 2026Grant or award281,879 shares · $0Avg. price $01,256,037 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsFilings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Bausch Plus Lomb (BLCO) stock information
NYSE
Bausch Plus Lomb (BLCO) is listed on NYSE. Its market capitalization is about $7.5B. On trailing-twelve-month earnings the P/E ratio is -67.83, and the P/B ratio is 1.17. Return on equity is -1.7%. These figures are computed in-house from official filings and are reference information only.
Bausch Plus Lomb — frequently asked questions
- What is the P/E ratio of Bausch Plus Lomb (BLCO)?
- On a trailing-twelve-month basis, BLCO trades at a P/E ratio of -67.83. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Bausch Plus Lomb?
- BLCO has a market capitalization of about $7.5B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.